Successful Treatment of Refractory Folliculitis Decalvans with Secukinumab

The letter reported a successful case of treating refractory folliculitis decalvans with secukinumab. Folliculitis decalvans is a chronic inflammatory condition leading to scarring hair loss, and it is often resistant to conventional treatments. The authors, Fathima Ferial Ismail and Rodney Sinclair, described the use of secukinumab, an IL-17A inhibitor, which resulted in significant clinical improvement in a patient who had not responded to other therapies. This case highlighted the potential of secukinumab as an effective treatment option for this challenging condition.